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Genetically encoded effectors are important tools
for probing cellular function in living animals, but
improved methods for directing their expression to
specific cell types are required. Here, we introduce
a simple, versatile method for achieving cell-type-
specific expression of transgenes that leverages the
untapped potential of ‘‘coding introns’’ (i.e., introns
between coding exons). Our method couples the
expression of a transgene to that of a native gene
expressed in the cells of interest using intronically
inserted ‘‘plug-and-play’’ cassettes (called ‘‘Trojan
exons’’) that carry a splice acceptor site followed by
the coding sequences of T2A peptide and an effector
transgene. We demonstrate the efficacy of this
approach in Drosophila using lines containing suit-
able MiMIC (Minos-mediated integration cassette)
transposons and a palette of Trojan exons capable
of expressing a range of commonly used transcrip-
tion factors. We also introduce an exchangeable,
MiMIC-like Trojan exon construct that can be tar-
geted to coding introns using the Crispr/Cas system.INTRODUCTION
Genetically based tools for perturbing cellular function are
increasingly used to study the contributions of different cell types
to development, physiology, and behavior. The utility of these
tools depends critically on the cell-type specificity of their
expression, and there is considerable demand for targeting
methods with greater selectivity than is currently available. In
general, selectivity of expression is achieved by using DNA reg-
ulatory elements of one or more genes normally expressed by
a cell type of interest to drive the expression of a primary
transgene, such as Gal4 or Cre; the primary transgene can
then activate the expression of secondary transgenes that1410 Cell Reports 10, 1410–1421, March 3, 2015 ª2015 The Authorsmediate functional perturbations (Branda and Dymecki, 2004;
Venken et al., 2011b; Yizhar et al., 2011).
Co-opting a gene’s full complement of regulatory elements
to faithfully target all the cells that express it has been
best achieved by inserting a transgene coding sequence into
one of its translated exons (Demir and Dickson, 2005; Diao
and White, 2012; Taniguchi et al., 2011). This approach, how-
ever, is labor intensive and lacks the convenient modularity of
less-precise targeting systems, such as transposon-based sys-
tems, in which recombinase-mediated cassette exchange
(RMCE) can be used to swap primary transgenes (Gohl et al.,
2011).
A targeting method that combines the simplicity of RMCE
with the precision of directly coupled transgene and native
gene expression for use with fly lines that carry the engineered
transposable element MiMIC (i.e., Minos-mediated integration
cassette) was recently described in Drosophila (Venken et al.,
2011a). When a MiMIC insertion is in the 50 UTR of the gene
of interest, RMCE can be used to replace the MiMIC cassette
with an artificial exon encoding a primary transgene, preceded
by a universal splice acceptor. The splice acceptor insures
inclusion of the transgene coding sequence in the mature
message of the native gene, and the transgene’s start methio-
nine, rather than the native gene’s, directs its translation.
Although a similar strategy can be used to introduce artificial
exons into MiMIC insertions within coding introns, which are
two-and-a-half times more numerous than 50 UTR intron inser-
tions (Venken et al., 2011a), co-translation of these artificial
exons produces fusion proteins that will not predictably retain
the function of a primary transgene’s product. Therefore the
MiMIC method’s utility for gaining genetic access to cell types
of interest is currently limited to genes with MiMIC insertions in
50 UTR introns, and most Drosophila genes lack any MiMIC
insertion.
To overcome these limitations, we have created an inte-
grated toolkit of artificial exons that capitalize on the ability
of the viral T2A peptide to promote the translation of a
second protein product from a single transcript (Diao and
White, 2012; Tang et al., 2009). Incorporation of the T2A
sequence permits transcriptional effectors encoded by our
artificial exons to be expressed from sites within coding introns
and thus extends the ‘‘plug-and-play’’ flexibility of the MiMIC
system to this important class of intron. We have further
extended the capabilities of our toolkit by creating an artificial
exon that can be targeted to a coding intron in any gene of in-
terest by using the recently developed Crispr/Cas technology
(Gratz et al., 2013). This allows most genes in the fly genome
to serve as gateways to genetically access to the cells that ex-
press them.
By analogy to the Trojan horse, we call our artificial exons
‘‘Trojan exons’’ because they gain access to cells through their
insertion into coding introns and ‘‘release’’ transcriptional effec-
tors that render the cells susceptible to exploitation by other
transgenes. The palette of Trojan exons presented here includes
most of the transcriptional effectors commonly used in the
fly and enables the fast and easy creation of driver lines with
high-fidelity expression in the pattern of an endogenously ex-
pressed gene. Although developed for use in Drosophila, the
Trojan exon approach should be readily adaptable for use in
other genetic model organisms.
RESULTS
Tools for Creating Gal4 Drivers from MiMIC Lines with
Inserts into Coding Introns
We have previously shown that the T2A peptide can effectively
promote the expression of a Gal4 transgene in the pattern of a
nativeDrosophila gene of interest when the T2A and Gal4 coding
sequences are fused in-frame to the coding sequence of the
native gene by homologous recombination (Diao and White,
2012). To simplify this procedure for Drosophila genes that
contain MiMIC transposons in coding introns, we have adapted
the protein-trap vectors previously developed by Venken et al.
(2011a) to permit insertion of the T2A-Gal4 sequences directly
into the mature message of the native gene by mRNA splicing
(Figure 1A; Table 1). Embryonic injection of such a vector into
germline cells expressing FC31 integrase leads to exchange of
the T2A-Gal4-containing cassette, thus producing a Gal4 driver
line that has an expression pattern corresponding to that of a
native gene.
Because approximately 10% of Drosophila genes currently
have MiMIC insertions into coding introns, a wide selection of
genes is amenable to this technique (Nagarkar-Jaiswal et al.,
2015; http://flypush.imgen.bcm.tmc.edu/pscreen/mimic.html).
To test its efficacy, we focused on genes of neurobiological inter-
est because of the nervous system’s large array of cell types and
also because cell-type specific targeting has found its greatest
use in mapping neuronal circuits. Two genes of considerable
neurobiological interest for which high-fidelity Gal4 lines have
been lacking are those encoding the vesicular glutamate trans-
porter (i.e., VGlut; Figure 1B), and choline acetyltransferase
(i.e., Cha; Figure 1C), which are expressed in neurons that use
glutamate and acetylcholine as neurotransmitters, respectively.
Both genes contain intronicMiMIC inserts (VGlutMI04979, phase 2;
ChaMI04508, phase 0) that are common to all splice isoforms of the
respective genes, and for both, there are Gal4 driver lines made
by other methods (Mahr and Aberle, 2006; Salvaterra and Kita-
moto, 2001). These lines thus permit the direct comparison ofCecommonly used drivers with those generated by the Trojan-
mediated conversion of MiMIC (Trojan-MiMIC) technique
described here.
Targeting Glutamatergic and Cholinergic Neurons using
a Trojan Gal4 Exon
Trojan-MiMIC lines were created as described in the Experi-
mental Procedures, with recombinant flies identified directly by
Gal4-driven expression of a fluorescent reporter in the G1 gener-
ation (Figure S1A). Cassette replacement was also later verified
by PCR. The VGlut and Cha genes are broadly expressed in the
nervous system, so reporter-mediated fluorescence was readily
detectable in live larvae, and driver lines could be established
within two generations. Both Trojan-MiMIC drivers exhibited
expression patterns broadly consistent with the expression of
their respective genes (Daniels et al., 2008; Yasuyama et al.,
1995): VGlutMI04979-Gal4 targets GFP reporter expression to
larval motor neurons (Figures 1B’ and B’’), while ChaMI04508-
Gal4 targets most central neurons and also peripheral sensory
neurons (Figure 1C’). Comparison of these patterns with those
obtained for the Cha gene by in situ hybridization at the embry-
onic stage (Figure 1C’’) or for the VGlut protein by immunostain-
ing at the larval stage (data not shown) confirmed their general
fidelity, as did the substantial rescue from embryonic lethality
of expression of a UAS-Cha transgene under the control of
ChaMI04979-Gal4 (Table 2). The one noted exception to fidelity
of expression was a set of neurons in the posterior optic lobe
that is clearly labeled by the VGlutMI04979-Gal4 driver, despite
not being readily detected by anti-VGlut antiserum (Figure S2).
These neuronal somata, which may simply stain below the
detection threshold of the anti-VGlut antibody, are likewise
included in the expression pattern of an enhancer-trap line
widely used to target glutamatergic neurons, OK371-Gal4
(Mahr and Aberle, 2006).
For a more detailed assessment of the fidelity of the
VGlutMI04979-Gal4 and ChaMI04508-Gal4 lines, we examined their
expression in three pairs of medial, segmentally repeated neu-
rons in the larval ventral nerve cord (VNC) identifiable by their
expression of the Even-skipped protein, Eve (Fujioka et al.,
2003). Two pairs of Eve+ neurons, aCC and RP2, are known glu-
tamatergic motor neurons (Vactor et al., 1993), while the third,
pCC, is a putative cholinergic interneuron. Consistent with their
neurotransmitter phenotypes, both aCC and RP2motor neurons
are within the expression pattern of the VGlutMI04979-Gal4 line
(Figures 1B’’’, left, and 1B’’’’), while only pCC is included in the
pattern of the ChaMI04508-Gal4 line (Figure 1C’’’, left), strongly
suggesting that pCC is cholinergic. An existing cholinergic
driver, Cha7.4-Gal4, which was made using a 7.4-kb genomic
fragment located upstream of the Cha coding sequence, also la-
bels the pCC pair, but inconsistently, and often labels the gluta-
matergic aCC motor neurons (Figures 1C’’’, right, and 1C’’’’).
Similarly, OK371-Gal4 fails to express consistently in the gluta-
matergic motor neurons, often not labeling RP2 (Figures 1B’’’,
right, and 1B’’’’). The two driver lines made using the Trojan-
MiMIC method thus display a high degree of fidelity when
compared with similar drivers made by other methods. The
consistent labeling of pCC interneurons by ChaMI04508-Gal4
also suggests that Trojan-MiMIC drivers can serve as highlyll Reports 10, 1410–1421, March 3, 2015 ª2015 The Authors 1411
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sensitive detectors of gene expression to identify neurotrans-
mitter and other cellular phenotypes.
Targeting Larval Muscle using a Trojan Gal4 Exon
In addition to targeting neurons based on their neurotransmitter
phenotypes, the Trojan-MiMIC technique can similarly be used
to target cells that receive input from such neurons by exploiting
MiMIC insertions into genes that encode subunits of specific
neurotransmitter receptors. The larval bodywall muscles inner-
vated by glutamatergic motor neurons express five different
glutamate receptor genes (DiAntonio, 2006), two of which—
GluRIIB and GluRIIE—have MiMIC insertions in coding introns
(Figure 1D). We created the GluRIIBMI03631- and GluRIIEMI01909-
Gal4 driver lines, which, as expected, expressed Gal4 in all larval
bodywall muscles (Figure 1D’), though the patterns generated
by GluRIIEMI01909-Gal4 were weaker than those generated by
GluRIIBMI03631-Gal4 and exhibited some variegation.
We also examined the expression of the GluRIIB and GluRIIE
genes in adult animals, where the subunit composition of gluta-
mate receptors at neuromuscular junctions is largely unknown.
While GluRIIBMI03631-Gal4 does not drive observable reporter
expression in any muscle in 1-week-old adults, GluRIIEMI01909-
Gal4 produced a distinct pattern of expression in ventral muscles
of the abdomen (Figure 1D’’). We again observed variegation,
sometimes quite pronounced, which has been previously docu-
mented for other Gal4 lines (Skora and Spradling, 2010). How-
ever, such variation is the exception, and most Trojan-MiMIC
Gal4 insertions yield robust and stable expression patterns.
Efficiency of Generating Trojan-MiMIC Gal4 Lines
We have successfully generated two or more Trojan-MiMIC lines
for each of the Trojan Gal4 exons in the three possible reading
frames (Table 1). The efficiency of cassette exchange using the
microinjection protocol ranged from 3% to 33% (i.e., percentage
of fertile adults from Trojan-Gal4-injected embryos that yieldedFigure 1. Creating Trojan Gal4 Driver Lines using MiMIC Insertions int
(A) Trojan exon structure, integration, and expression. The flanking inverted attP si
black) permit FC31 integrase-mediated exchange for a Trojan exon cassette, via
the T2A-transgene sequence into the gene’s mRNA; a short linker with one of thre
sequence causes truncation of the native gene product and promotes the transla
Figures S1A and S6.
(B) Schematic of the VGlut gene (RC isoform) and site of MiMICMI04979 insertion
expression of a UAS-myr::GFP reporter in many neurons of the larval CNS (arrowh
Scale bar, 200 mm. See also Figure S2. (B’’) Motor nerves (labeled as in B’) in an em
(magenta). Scale bar, 25 mm. (B’’’) Comparison of the VGlutMI04979-Gal4 (left) and
ments of the larval VNC, labeled with an anti-Eve antibody (magenta). Two of the th
hemisegment, aCC (open arrowhead) and RP2 (filled arrowhead), are glutamaterg
(B’’’’) Bar graph summarizing the results of labeling experiments of the type shown
(C) Schematic of the Cha gene (RB isoform) and site of the MiMICMI04508 insertion
expression of a UAS-myr::GFP reporter in most neurons of the larval CNS (arrow
bar, 200 mm. (C’’) Co-localization of VAChT mRNA, visualized by embryonic fluor
(middle). Bottom: merged images (green, UAS-myr::GFP; magenta, VAChT mRN
and Cha7.4-Gal4 (right) expression patterns (green, UAS-nlsGFP) in three hemis
neurons (outlined), Cha7.4-Gal4 consistently labels the glutamatergic aCC neuron
10 mm. (C’’’’) Bar graph summarizing the results of labeling experiments of the
hemisegments.
(D) Schematics of the GluRIIB and GluRIIE genes and the insertion sites of MiM
dorsal view) and GluRIIEMI01909-Gal4 (right panel; ventral view) in larval bodywall m
panel) drives expression in adult ventral abdominal muscles. Scale bars in (D’) a
CeGal4-expressing progeny). Overall, recombinant progeny were
identified for 15 of 16 independent MiMIC insertions tested,
although for several genes, we could not establish stocks, and
in some cases, recombinant animals were poorly viable. While
truncation of the endogenous gene product by the introduction
of T2A-Gal4 may, in some cases, have created a dominant-
negative version of the endogenous protein with deleterious
effects, such effects were not consistently observed for all Trojan
exons introduced into the same locus. For example, heterozy-
gous Gad1MI09277-Gal4 animals were severely impaired, but het-
erozygous Gad1MI09277-p65AD animals were viable and healthy
(Table 1), suggesting that the Trojan exons encoding the different
transcriptional effectors may be spliced with different efficacies.
In any case, our findings suggest that the majority of MiMIC sites
in coding introns can be converted into viable Trojan-MiMICGal4
lines by microinjection techniques.
In Vivo Generation of Trojan-MiMIC Gal4 Driver Lines
Because microinjection is both expensive and laborious, we
also designed a cheaper system for generating Trojan-MiMIC
Gal4 flies that relies on simple genetic crosses and that can
produce large numbers of recombinants. We created fly lines
carrying either single or ‘‘triplet’’ Trojan donor constructs
(Table 1), which generate attB-flanked integration cassettes
when excised from the genome. The more universally useful
triplet donor has three cassettes (Figure 2A), each containing
a Trojan Gal4 exon in one of the three reading frames. Each
Trojan exon is flanked by attB sites and a pair of uniquely
compatible lox sites, which are substrates of the Cre recom-
binase (Livet et al., 2007). By crossing flies from this triplet
donor line to flies with germline expression of both Cre
recombinase and FC31 integrase, one can induce Cre-medi-
ated excision and circularization of the three cassettes, which
can then be integrated into the attP sites of a MiMIC insertion
by FC31 integrase (Bischof et al., 2007).o Coding Introns
tes (P) of aMiMIC cassette (gray) within a coding intron of a gene (coding exons,
its flanking attB (B) sites. The splice acceptor site (SA) insures incorporation of
e possible lengths maintains the reading frame of the native message; the T2A
tion of Gal4 (or other transgene, X). pA, Hsp70 polyadenylation signal. See also
in a coding intron common to all splice isoforms. (B’) VGlutMI04979-Gal4 drives
ead) includingmotor neurons, which project axons (arrow) to bodywall muscles.
bryonic fillet showing peripheral nerves double labeled with anti-Fas2 antibody
OK371-Gal4 (right) expression patterns (green, UAS-nlsGFP) in three hemiseg-
ree Eve-immunopositive neurons located dorsally at the ventral midline in each
ic, but OK371-Gal4 consistently fails to label RP2. Scale bar, represents 10 mm.
in (B’’’) from VGlutMI04979-Gal4 (n = 36) and OK371-Gal4 (n = 72) hemisegments.
in a coding intron common to all splice isoforms. (C’) ChaMI04508 -Gal4 drives
head) and sensory neurons of the peripheral nervous system (sn, arrow). Scale
escence in situ hybridization (top) and ChaMI04508 -Gal4 driven UAS-myr::GFP
A). Scale bar represents 25 mm. (C’’’) Comparison of the ChaMI04508 -Gal4 (left)
egments of the larval VNC labeled with anti-Eve antibody. Of the three Eve+
s (open arrowheads), but not the putative cholinergic pCC neurons. Scale bar,
type shown in (C’’’) from ChaMI04508-Gal4 (n = 90) and Cha7.4-Gal4 (n = 72)
ICMI03631 and MiMICMI01909. (D’) Expression of GluRIIBMI03631-Gal4 (left panel;
uscles. (D’’) GluRIIEMI01909-Gal4 (right panel), but not GluRIIBMI03631-Gal4 (left
nd (D’’) represent 150 mm. Green, UAS-EYFP.
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Table 1. Trojan Exons, Fly Lines, and MiMIC Insertions Used or Generated
Transgene Trojan Exon Plasmid Genes/MiMIC Inserts for Fly Lines Made Developmentally Lethala Poor Viabilityb
Gal4 pBS-KS-attB2-SA(0)-T2A-Gal4-Hsp70 RdlMI02620, ChaMI04508 CCAPMI01341 (no recombinants)
pBS-KS-attB2-SA(1)-T2A-Gal4-Hsp70 GluRIIEMI01909, ShawMI01735, CCAP-RMI05804,
Hr46MI04877, jebMI03124
Hr46MI00362, E75MI04895, abMI01579 jebMI03124
pBS-KS-attB2-SA(2)-T2A-Gal4-Hsp70 GluRIIBMI03631, VGlutMI04979, Gad1MI09277 Gad1MI09277
pBS-KS-attB2-SA(0)-T2A-Gal4c
pBS-KS-attB2-SA(1)-T2A-Gal4c Hr46MI04877, CCAPRMI05804 E75MI04895, crcMI02300
pBS-KS-attB2-SA(2)-T2A-Gal4c VGlutMI004979
pC-(loxP2-attB2-SA(0)-T2A-Gal4-Hsp70) (i.e., singlet donor)
pC-(loxP2-attB2-SA(1)-T2A-Gal4-Hsp70) (i.e., singlet donor)
pC(loxP2-attB2-SA(2)-T2A-Gal4-Hsp70) (i.e., singlet donor)
pC-(lox2-attB2-SA-T2A-Gal4-Hsp70)3 (i.e., triplet donor) amonMI00899, RdlMI02957, Gycb100B/stopsMI01568 CCAPMI01341 (no recombinants) amonMI00899
pT-GEM(attP2-SA(0)-T2A-Gal4-Hsp70-lox2-3XP3-RFP) pburs-intron 1
pT-GEM(attP2-SA(1)-T2A-Gal4-Hsp70-lox2-3XP3-RFP)
pT-GEM(attP2-SA(2)-T2A-Gal4-Hsp70-lox2-3XP3-RFP)
3XGal80 pBS-KS-attB2-SA(0)-T2A-3XGAL80-HSP70
pBS-KS-attB2-SA(1)-T2A-3XGAL80-HSP70
pBS-KS-attB2-SA(2)-T2A-3XGAL80-HSP70 VGlutMI04979
Gal4DBD pBS-KS-attB2-SA(0)-T2A-GAL4DBD-Hsp70 cacMI02836, ChaMI04508
pBS-KS-attB2-SA(1)-T2A-GAL4DBD-Hsp70
pBS-KS-attB2-SA(2)-T2A-GAL4DBD-Hsp70 VGlutMI04979
dVP16AD pBS-KS-attB2-SA(0)-T2A-dVP16AD-Hsp70
pBS-KS-attB2-SA(1)-T2A-dVP16AD-Hsp70 ShawMI01735
pBS-KS-attB2-SA(2)-T2A-dVP16AD-Hsp70
p65AD pBS-KS-attB2-SA(0)-T2A-P65AD-Hsp70 amonMI00899
pBS-KS-attB2-SA(1)-T2A-P65AD-Hsp70 ShawMI01735, RdlMI02957
pBS-KS-attB2-SA(2)-T2A-P65AD-Hsp70 Gad1MI09277
QF2 pBS-KS-attB2-SA(0)-T2A-QF2-Hsp70 ChaMI04508 amonMI00899
pBS-KS-attB2-SA(1)-T2A-QF2-Hsp70
pBS-KS-attB2-SA(2)-T2A-QF2-Hsp70 VGlutMI04979, Gad1MI09277
LexA:QFAD pBS-KS-attB2-SA(0)-T2A-LexA:QFAD-Hsp70 ChaMI04508
pBS-KS-attB2-SA(1)-T2A-LexA:QFAD-Hsp70
pBS-KS-attB2-SA(2)-T2A-LexA:QFAD-Hsp70 VGlutMI04979, Gad1MI09277
aLines for which recombinants died developmentally (or, as for CCAPMI01341, no recombinants were recovered).
bLines in which animals had impaired viability.
cThese Trojan Gal4 vectors lack the Hsp70 pA and are designed to retain a gene’s native transcription termination signals (e.g., when microRNA binding sites are present in the 30 UTR). For two
genes analyzed, we found no detectable differences in the expression patterns obtained with these constructs compared with those obtained with constructs containing the Hsp70 pA. We
recommend use of the latter constructs to insure robust transcription termination unless mRNA downregulation is a known or suspected problem.
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Table 2. UAS-Cha Rescues the Hatching Deficits of ChaMI04508-
Gal4/ChaL13 Mutants
Crossa
Expected %
ChaMI04508-
Gal4/ChaL13
Mutant
Phenotype (%)b
Control Cha
MI04508­ Gal4
TM3;Sb X
ChaL13
TM6B;Tb 25 29 (n = 120/416)
Rescue Cha
MI04508­ Gal4
TM3;Sb X
ChaL13 ; UAS­Cha
TM6B;Tb 25 1 (n = 4/368)
aEmbryos from the indicated crosses were collected for 1 hr and incu-
bated for 22.5 hr at 25C. Unhatched embryos were dechorionated and
individually prodded to test for mutant-like phenotypes (i.e., no response
or incomplete peristalsis).
bOnly progeny with ChaMI04508-Gal4/ChaL13 genotypes, which should
occur at a frequency of 25% assuming Mendelian segregation ratios,
are expected to have mutant phenotypes. The almost complete absence
of mutant phenotypes when UAS-Cha is included in the cross indicates
strong rescue of the embryonic lethality associated with Cha null
mutations.To test this ‘‘in vivo’’ Trojan-MiMIC system, we selected
MiMIC insertions in three genes, each of which required a
T2A-Gal4 construct in a different reading frame: (1) Guanylyl
Cyclase Beta-100B (Gycb100BMI01568; ph 2; Figure 2B), which
encodes a subunit of the nitric-oxide-sensitive soluble guanylyl
cyclase (Shah and Hyde, 1995); (2) Resistant to Dieldrin
(RdlMI02957, ph 1; Figure 2C) which encodes a well-character-
ized Drosophila GABA-A receptor a-subunit (Buckingham
et al., 2005); and (3) amontillado (amonMI00899, ph 0; Figure 2D),
which encodes the Drosophila ortholog of Prohormone Conver-
tase 2, an enzyme critical for the processing of neuropeptides
(Wegener et al., 2011). Gal4 lines were successfully generated
for these three genes (Figure S1B), confirming that all three Tro-
jan Gal4 constructs of the triplet donor are functional. In addi-
tion, all three appeared to be excised from the donor locus
and re-integrated into the MiMIC site with similar efficiency,
as determined by PCR analysis of all 61 independent exchange
events produced in the generation of the Gycb100BMI01568-Gal4
line (Figure S3). In total, eight exchange events resulted in phase
2 insertions with the robust Gycb100BMI01568-Gal4 CNS expres-
sion pattern seen in Figure 2B’. Interestingly, nine phase 1 inser-
tions in the opposite direction gave expression patterns that
were largely non-neural (data not shown) due to the fortuitous
intronic localization of MI01568 in a second gene (i.e., stops) en-
coded on the opposite strand.
The expression patterns of both the RdlMI02957- and
amonMI00899-Gal4 lines conform closely to those reported for
the Rdl and amon genes, respectively (Harrison et al., 1996; We-
gener et al., 2011). RdlMI02957-Gal4 drives reporter expression
broadly in the adult brain, most notably in structures previously
identified by antibody staining to express Rdl protein, including
the mushroom body lobes, the ellipsoid body, and the antennal
lobes (Figure 2C’). In addition, expression of a UAS-Rdl-RA
transgene (Sa´nchez-Soriano and Prokop, 2005) eliminated larval
lethality in animals mutant for Rdl (data not shown). Despite
some lethality later in development, surviving adults bearing
the rescue transgene were fertile and could be propagated as
a stable stock, indicating that the RdlMI02957-Gal4 expression
pattern includes all essential Rdl-expressing neurons. Notably,
the expression pattern of the RdlMI02957-Gal4 line contrasts toCethe more restricted patterns produced by two previously pub-
lished promoter-fusion Rdl-Gal4 lines (Hekmat-Scafe et al.,
2010; Yuan et al., 2014), neither of which exhibited expression
in all previously characterized sites of Rdl expression (Figure S4).
The Rdl-Gal42-2 line, which has a second chromosome trans-
gene insertion and could therefore be readily assayed for its
ability to rescue the larval lethality of Rdl mutations, failed to
do so (data not shown).
As expected, the amonMI00899-Gal4 line expression pattern
included many neurons with the large somata characteristic
of neurosecretory cells (Figure 2D’, upper panel), including a
well-known group that express crustacean cardioactive peptide
(i.e., CCAP; Figure 2D’’, upper panels). This group is likewise
present in the expression pattern of a Gal4 line made by
P-element transgenesis using a putative amon enhancer
element (Rhea et al., 2010) (amon-Gal4; Figures 2D’ and 2D’’,
lower panels). However, the latter line has both weaker and
sparser expression than amonMI00899-Gal4 in the nervous sys-
tem, and, unlike amonMI00899-Gal4, fails to label the peripheral
endocrine cells (i.e., Inka cells) that make the peptide ecdysis
triggering hormone (ETH; Figure 3D’’’). Evidence for amon
gene expression in Inka cells has been ambiguous: amon
mRNA is found in embryonic Inka cells by in situ hybridization
(Siekhaus and Fuller, 1999), but larval Inka cells are reported
to lack Amon immunoreactivity (Park et al., 2004; Rayburn
et al., 2009). To determine whether Inka cells express the
amon gene, we selectively knocked down its expression using
an Inka-cell-specific driver (ETH-Gal4) and UAS-amon-RNAi.
We found substantial developmental deficits in ecdysis at all
stages of development as is expected for loss of ETH function
(Figure S5). This result strongly suggests that Amon protein is
present at levels below the threshold of antibody detection
and that the amonMI00899-Gal4 line, but not the amon-Gal4
line, faithfully reports its expression.
Creating Trojan-MiMIC Lines for Combinatorial
Expression
It is often necessary to genetically target specific cells based not
on their expression of a single gene of interest but on their
expression of two such genes (Luan and White, 2007; Pfeiffer
et al., 2010; Potter et al., 2010). To permit such combinatorial tar-
geting, we created Trojan exons for several transgenes other
than Gal4 (Figure 1A; Table 1), including the Gal4 inhibitor,
Gal80, which effects a Boolean NOT operation when used in
conjunction with Gal4 drivers, and components of the Split
Gal4 system (Gal4DBD, dVP16AD, and p65AD), which can be
used in combination to perform a Boolean AND operation and
identify neurons common to the patterns of expression of two
genes.
The 3XGal80 Trojan exon (see Experimental Procedures) is de-
signed to express three copies of Gal80, one of which is tagged
with epitopes for hemagglutinin (HA) and FLAG and another of
which is tagged with EGFP. A VGlutMI04979-3XGal80 line gener-
ated with this construct has the same fidelity of expression
as VGlutMI04979-Gal4, as demonstrated by double labeling with
anti-VGlut and anti-GFP antibodies (Figure 3A), and effectively
subtracts glutamatergic neurons from the expression pattern
of the pan-neural elav-Gal4 driver line (Figure 3B). Similarly, anll Reports 10, 1410–1421, March 3, 2015 ª2015 The Authors 1415
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Figure 2. Creating Gal4 Drivers using the
In Vivo System for Trojan Exon Exchange
(A) Schematic of the triplet donor construct con-
sisting of three tandem Trojan Gal4 cassettes,
one in each reading frame, each flanked by attB
sites nested within uniquely compatible pairs of
lox sites, recognized by Cre recombinase. See
Figure S1B for details of genetic crosses.
(B) Schematic of the Gycb100B gene locus and
the site of the MiMICMI01568 insertion, which also
lies within a coding intron of the stops gene on
the opposite strand. See also Figure S3. (B’)
Expression of a UAS-EYFP reporter driven by
Gycb100BMI01568-Gal4 in the optic lobe (ol) of the
adult brain.
(C) Schematic of the Rdl gene and the
MiMICMI 02957 insertion site. (C’) Confocal images
from an adult brain show prominent RdlMI02957-
Gal4 driven expression of a UAS-EYFP reporter
in the mushroom bodies (mb), ellipsoid body (eb),
and antennal lobes (al). Scale bars, 50 mm. See
also Figure S4.
(D) Schematic of the amon gene and the
MiMIC MI00899 insertion site. (D’–D’’’) Comparison
of larval expression patterns of amonMI00899-Gal4
(top) and amon-Gal4 (bottom). (D’) Expression
patterns in CNS whole mounts (green, UAS-
EGFP). (D’’) Expression within the subset of
CCAP-expressing neurons (anti-CCAP staining,
magenta). Insets show higher-magnification im-
ages of the boxed regions. (D’’’) Expression
of amonMI00899-Gal4, but not amon-Gal4, in the
endocrine Inka cells located at the base of the
dorsal tracheal trunks (arrowheads). See also
Figure S5. Scale bars in (D’) and (D’’) represent
50 mm; scale bar in (D’’’) represents 10 mm.amonMI00899-p65AD line has a neuronal expression pattern that
matches that of the previously described amonMI00899-Gal4 line
(Figure 3C, left), as revealed by using it in conjunction with an
elav-Gal4DBD hemidriver, and can be used to target the sub-
population of CCAP-expressing neurons (Figure 3C, middle),
when used in conjunction with a CCAP-Gal4DBD hemidriver.
Importantly, restriction of expression can be used to identify
and manipulate previously inaccessible subsets of neuropepti-
dergic neurons. For example, amonMI00899-p65AD together
with VGlutMI04979–Gal4DBD unveils the class of peptidergic neu-
rons that also use the neurotransmitter glutamate. This class can
be seen to include putative motor neurons along the ventral1416 Cell Reports 10, 1410–1421, March 3, 2015 ª2015 The Authorsnerve cord that express the neuropeptide
proctolin (Anderson et al., 1988), and
numerous other central neurons (Fig-
ure 3C, right). In the same way, a
ShawMI01735-dVP16AD line in conjunction
with a Burs-Gal4DBD line isolates a sub-
population of neurons that expresses
both the Shaw K+ channel and the Burs
subunit of the hormone bursicon
(Figure 3D).
Overlap of two expression patterns and
a variety of dual manipulations can alsobe accomplished using orthogonal binary expression systems
(Lai and Lee, 2006; Potter et al., 2010), and to facilitate such ap-
plications, we created Trojan exons for the transcriptional activa-
tors QF2 and LexA::QFAD (Riabinina et al., 2015), which drive the
expression of transgenes placed downstream of QUAS and
LexAop sequences, respectively (Table 1). We applied these re-
agents to the question of whether acetylcholine and glutamate
are used as neurotransmitters by distinct populations of neu-
rons. While this is thought to be the case, a comprehensive com-
parison has not been possible with existing tools. Using
ChaMI04508-LexA::QFAD and VGlutMI04979-QF2 driver lines
together, we surveyed the neurons of early first instar larvae
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Figure 3. Combinatorial Gene Targeting using
Gal80, Split Gal4, QF2, and LexA::QFAD Trojan
Exons
(A and B) Suppression of Gal4 activity in glutamatergic
neurons using 3XGal80FLAG/HA/EGFP. (A) VGlutMI04979-
3XGal80FLAG/HA/EGFP expresses Gal80 (left; anti-GFP im-
munostaining) in glutamatergic motor neurons of the larval
VNC labeled with anti-VGlut antibody (middle); merged
images (right). Scale bar (A–E), 25 mm. (B) elav-Gal4 drives
UAS-LacZ reporter in the glutamatergic motor neurons
(rectangle: anti-LacZ immunoreactivity, magenta; anti-
VGlut, green), but Gal4 activity is absent when the
VGlutMI04979-3XGal80 transgene is present (right).
(C) Identification of neuronal subsets within the
amonMI00899-p65AD expression pattern. Left: the entire
complement of amon-expressing neurons in the larval CNS,
visualized using the pan-neuronal elav-VP16AD hemidriver
and a UAS-EGFP reporter. Middle: the CCAP-expressing
complement, visualized using a CCAP-Gal4DBD hemi-
driver. Right: the VGlut-expressing complement, visualized
using a Trojan-MiMIC VGlutMI04979-Gal4DBD hemidriver.
(D) Split Gal4 isolation of the subset of neurons that
express both the Shaw K+ channel and the hormone
Bursicon. Left: neurons expressing the RA, RC, and RE
splice isoforms of the Shaw gene, visualized using a Trojan-
MiMICShawMI01735-Gal4 driver line and a UAS-EGFP
reporter. Middle: the Shaw-expressing neurons that also
express Burs, isolated using a Trojan-MiMIC ShawMI01735-
dVP16AD in combination with a Burs-Gal4DBD hemi-
driver; green, UAS-EGFP. Right: anti-Burs immunostaining
(magenta) of the section shown in middle panel (double-
labeled neurons are white).
(E) Double labeling of the embryonic VNC to identify
subsets of cholinergic (LexAop-mCherry, magenta) and
glutamatergic (QUAS-mCD8-GFP, green) neurons using
orthogonal Trojan-MiMIC drivers. Left: expression pattern
of a ChaMI04508-LexA::QFAD driver in a confocal section
through the ventral midline. Middle: same section showing
expression of a VGlutMI04979-QF2 driver. Right: merged
images; note the two expression patterns do not overlap.
(F) Double labeling of glutamatergic neurons in the
larval CNS and body wall muscles using the orthogonal
Trojan-MIMC drivers VGlutMI04979-T2A-LexA::QFAD (green,
LexAop2-myr::GFP) and GluRIIB
MI03631-T2A-Gal4 (magenta,
UAS-CD4-tdTomato). Right: magnified image of the boxed
region at left showing neuromuscular synapses. Scale bar,
100 mm.
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Figure 4. Targeting Coding Introns using
the T-GEM Vector and the Crispr/Cas
System
(A) Schematic of the Trojan-Gal4 Expression Mod-
ule (T-GEM), which includes a red fluorescent pro-
tein (RFP) selection marker expressed in the adult
eye that can be used to monitor genomic insertion.
The attP sites permit cassette exchange with any
other Trojan exon, and unique restriction sites at the
50 and 30 ends of the construct permit the insertion
of suitable homologous arms (HAR and HAL) for
targeting T-GEM to the desired intronic locus.
(B) Schematic of the pburs gene, showing the in-
tronic site targeted by Crispr/Cas for T-GEM inser-
tion. (B’–B’’’’) Confocal micrographs of a larval CNS
whole mount triple labeled for pbursTGEM-Gal4 (B’),
Pburs (B’’), and Burs, which heterodimerizes with
Pburs to form the hormone Bursicon (B’’’); merged
image of all three labels (B’’’’). Brackets: Pburs-
immunopositive cell bodies. Green, UAS-EGFP;
red, anti-Pburs immunoreactivity; blue, anti-Burs
immunoreactivity. Scale bar, 25 mm.and found no segmentally reiterated overlap in expression (Fig-
ure 3E), suggesting that specification of themain transmitter sys-
tems in the Drosophila nervous system is mutually exclusive.
Simultaneous targeting of different cell types can also be used
to label or manipulate both upstream and downstream partners
within an interacting pair. To demonstrate this application, we
made a VGlutMI04979-LexA::QFAD line to drive expression of
LexAop-transgenes in motor neurons and used it together with
the previously described GluRIIBMI03631-Gal4 line to simulta-
neously label both pre- and post-synaptic elements at the larval
neuromuscular junction (Figure 3F).
T-GEM: A MiMIC-Independent Application of the Trojan
Exon Approach
While the growing collection of MiMIC insertions in Drosophila is
an invaluable resource for the implementation of the Trojan-
MiMIC technique, MiMIC insertions into coding introns are still
not available for all fly genes. To make the ‘‘plug-and-play’’
versatility of Trojan exons more generally serviceable—both in
the fly and potentially in other model organisms—we created a
MiMIC-like Trojan Gal4 construct that can be targeted to
genomic loci by homologous recombination using the Crispr/
Cas technology (Gratz et al., 2013). Targeted insertion of this
Trojan-Gal4 expression module (T-GEM; Figure 4A) into an in-
tronic locus generates a Gal4 driver line that can be easily con-
verted by cassette exchange into any other type for which Trojan
exons have been created. To demonstrate the use of T-GEM, we
targeted its insertion to an intron in the pburs gene, which
encodes a subunit of the heterodimeric hormone Bursicon (Hon-
egger et al., 2008) (Figure 4B). The expression pattern of the re-
sulting PbursTGEM-Gal4 line includes four pairs of segmentally
repeated neurons in the larval ventral nerve cord previously1418 Cell Reports 10, 1410–1421, March 3, 2015 ª2015 The Authorsshown to exhibit anti-Pburs immunoreac-
tivity (Luo et al., 2005) (Figures 4B’ and
4B’’, brackets). In addition, the pattern in-
cludes several other pairs that are notimmunoreactive for Pburs but are immunoreactive for Burs, the
heterodimeric partner of Pburs (Figures 4B’’’ and 4B’’’’). The
observation that PbursTGEM-Gal4 driven reporter expression co-
incides with Burs expression in these neurons is consistent with
reports that only Burs/Pburs heterodimers have biological activ-
ity (Luo et al., 2005) and indicates, as in other cases, that the Tro-
jan exon driver is a more sensitive indicator of gene expression
than a corresponding antibody.
DISCUSSION
The Trojan exon tools introduced here permit the rapid produc-
tion of transgenic fly lines for cell-type-specific manipulation.
The advantages of the Trojan exon system include (1) fully
modular design using off-the-shelf, exchangeable Trojan con-
structs; (2) the ease of FC31-mediated cassette exchange after
the initial creation of a suitable target site; (3) the availability in
Drosophila of thousands of ready-made target sites in the form
of MiMIC lines with insertions into coding introns; (4) the ability
to create novel intronic target sites using the T-GEM vector,
which simultaneously creates a Gal4 driver; and (5) high-fidelity
co-expression of transgene and targeted native gene. While
genes lacking introns or genes for which the elimination of a sin-
gle allele is lethal are not amenable to the Trojan exon technique,
such genes are not numerous in Drosophila, and special cases,
such as essential genes on the X chromosome, can be easily
accommodated by the Trojan exon strategy (Figure S6). In cases
where the mutagenic nature of Trojan insertions adversely
affects viability, we find that different Trojan exons vary in their
degree of lethality, and the range of such exons introduced
here gives experimenters considerable latitude in making
gene- and cell-type-specific reagents.
For the majority of Drosophila genes tested, we found that
Trojan exon-generated driver lines duplicated the expression
pattern of the native gene with higher fidelity, and detected
its expression with greater sensitivity, than existing reagents
(see also Gnerer et al., 2015). As such, Trojan lines should serve
as a new ‘‘gold standard’’ in determining the expression pat-
terns of genes of interest. In addition, we have shown that Tro-
jan lines can be readily generated for intersectional analysis to
isolate previously inaccessible cell groups for characterization.
Overall, the Trojan exon technology introduced here facilitates
a range of cellular and genetic manipulations and allows them
to be performed with unprecedented speed and accuracy. It
does so by leveraging the largely unexploited capacity of cod-
ing introns to provide genetic access to specific cell types
in vivo. Its implementation in other organisms using Crispr/
Cas-mediated genome editing (Seruggia and Montoliu, 2014)
should be possible using strategies similar to the T-GEM tech-
nology introduced here.
EXPERIMENTAL PROCEDURES
Molecular Biology
Trojan Exon Constructs
All Trojan exons except the T-GEM construct were made by incorporating pri-
mary transgene coding sequences into the protein trap vectors introduced by
Venken et al. (2011a) for all three reading frames (Drosophila Genomics
Resource Center, clones #1297, 1305, and 1313; Indiana University). Trans-
gene coding sequences were amplified by PCR from the following sources:
pC-attB-bursa-mCD8-EGFP-T2A-Gal4 (Addgene #39463) (Diao and White,
2012) for Gal4; pBPZpGAL4DBDUw (Addgene #26233) (Pfeiffer et al., 2010)
and pBPp65ADZpUw (Addgene #26234) (Pfeiffer et al., 2010) for Gal4DBD
and p65AD, respectively; pCAST-CCAP-dVP16ADZip—used to create pP
{y+, dVP16AD} (Gao et al., 2008; Luan et al., 2006)—for dVP16AD; pattb-
nsyb-QF2-Hsp70 (Addgene #46115) for QF2 (Riabinina et al., 2015); and
pattb-nsyb-Lex::QF-Hsp70 (Addgene #46123) for LexA::QFAD. The T2A-
Gal80FLAG/HA-P2A-Gal80EGFP-T2A-Gal80-Hsp70 sequence was synthesized
by Epoch Life Science using the P2A and T2A sequences described in Diao
andWhite (2012) and the DrosophilizedGal80 sequence of Pfeiffer et al. (2010).
The pT-GEM vectors were assembled in pBlueScript from T2A-Gal4-Hsp70
sequencesmade as described above and a 3XP3 red fluorescent protein (RFP)
selection marker (Bischof et al., 2007) with flanking inverted loxP sites synthe-
sized by Epoch Life Science. To insert the T-GEM construct into the pburs
locus, homology arms of approximately 1 kb were amplified by PCR from
genomic DNA of the {nos-Cas9} attP2 transgenic fly line used for embryo
microinjection (Ren et al., 2013). The guide RNA expression construct (sgRNA)
wasmade by inserting a DNA fragment, produced by annealing the oligonucle-
otides ttcgAGAGTTCGCTAACTCTATAG and aaacCTATAGAGTTAGCGAA
CTCT, into the BbsI (New England Biolabs)-digested U6b-sgRNA-short
plasmid of Ren et al. (2013).
Triplet and Singlet Donor Constructs
The triplet donor construct was assembled from several synthesized gene
fragments. The attB2 and SA sequences were from Venken et al. (2011a);
the sequences of the loxP, loxN, and lox2272 sites were identical to those in
Livet et al. (2007); the unique 100-bp spacer sequences separating each
pair of lox and attB sites were derived from a 600-bp sequence in the promoter
of nerfin1, which lacks DNA regulatory elements (Kuzin et al., 2009); the T2A-
Gal4 sequencewas the same as used for the TrojanGal4 constructs. After syn-
thesis, the fragments were assembled and cloned into pCAST (Luan et al.,
2006) to make the final construct, pC-(lox2-attB2-SA-T2A-Gal4-Hsp70)3.
Singlet donor constructs were made similarly to the triplet donor constructs.
First, backbone fragments consisting of loxP-flanked attB2-SA sequences
were synthesized in all three phases and subcloned into the pCAST vector
(Luan et al., 2006) to make the pC-(loxP2-attB2-SA). A T2A-Gal4-Hsp70
fragment derived from the Trojan Gal4 construct by BamH I digestion wasCethen cloned into these vectors to make the pC-(loxP2-attB2-SA-T2A-Gal4-
Hsp70) singlet donor constructs.
TubP-dVP16AD, TubP-Gal4DBD, and ETH-Gal4 Constructs
Constructs in which the dVP16ADZip and ZipGal4DBDflUw sequences
described above were expressed under the tubulin-1a promoter (TubP)
were made by replacing the Gal80 sequence in the pCaSpeR4-tubP-Gal80
vector (gift of Tzumin Lee). The ETH-Gal4 construct was made by cloning a
397-bp promoter fragment lying just upstream of the ETH start methionine
into the pPTGAL vector (Sharma et al., 2002).
Fly Lines
MiMIC lines were obtained from the Bloomington Stock Center at Indiana Uni-
versity or the Bellen Lab of Baylor College of Medicine. The TubP-dVP16AD,
TubP-Gal4DBD, and ETH-Gal4 lines were made by P-element transformation,
and the insertions of TubP-dVP16AD and TubP-Gal4DBD on chromosomes X,
II, and III were isolated and characterized. An ETH-Gal4 insertion on chromo-
some II was used in the experiments described here. The following lines were
described previously: w;+;Burs-Gal4DBD (Luan et al., 2012) and w;Sp/CyO;
CCAP-Gal4DBD and yw;elav-Gal4DBD;Dr/TM3,Sb (Luan et al., 2006).
w;+;Rdl2-1-Gal4 and w;Rdl2-2-Gal4/CyO;+ were gifts from Dr. Julie Simpson
at Janelia Farm Research Campus, Howard HughesMedical Institute. All other
stocks were obtained (or derived from stocks) from the Bloomington
Drosophila Stock Center at Indiana University. All plasmid injections to
generate Trojan-MiMIC lines were performed by Rainbow Transgenic Flies.
A complete list of transgenic fly lines developed for use in implementing the
Trojan system is shown in Table S1.
Lines Made by FC31-Mediated Conversion of MiMIC Lines by
Plasmid Injection
Midiprep plasmid DNA containing the desired Trojan exon in the correct
reading frame was injected together withFC31 plasmid DNA into the embryos
of flies bearing MiMIC insertions in genes of interest. Recombinant transform-
ants were isolated as described in Figure S1, using UAS-2XEYFP, UAS-
2XEGFP, 13XLexAop2-myr-tdTomato, and QUAS-mCD8-GFP as fluorescent
expression markers. In some cases, developmental lethality was observed
that appeared to derive from high levels of fluorescent protein expression. In
these cases, G0 flies were crossed with flies from the yw;Sp/CyO;Dr/
TM3,Sb double balancer line, and y recombinant progeny, which had lost
the y+ selection marker associated with the MiMIC insertion, were isolated.
The orientation of the Trojan exon insert was then determined by PCR
amplification of the insertion. Since in general, the endogenous fluorescence
of the EGFP-tagged Gal80 moiety was too weak to detect in live animals,
this strategy was also used to screen for MiMIC-3XGal80FLAG/HA/EGFP-Hsp70
flies.
Lines Made In Vivo using the Triplet Donor Line
Flies bearing inserts of the triplet donor transgene were made by P-element-
mediated transformation using pC-(lox2-attB2- SA-T2A-Gal4-Hsp70)3. Lines
were established with insertions of the triplet donor on chromosomes X, II,
and III. A transgenic line with the second chromosome insert was used as
the Trojan Gal4 donor to make the Trojan-MiMIC Gal4 lines as described in
Figure S1.
PbursTGEM-Gal4 Line Made using pT-GEM
The PbursTGEM-Gal4 transgenic flies were made by microinjecting into em-
bryos of {nos-Cas9} attP2 flies (Ren et al., 2013) the sgRNA and pT-GEM
plasmid DNA. The adults were screened by fluorescence for eye-specific
expression of RFP.
Immunostaining, Fluorescent In Situ Hybridization, and Confocal
Microscopy
Fixation, staining, and confocal imaging of whole-mount CNS preparations
from third-instar larvae or adults were carried out as described previously
(Luan et al., 2012). Primary antibodies were used as described in the Supple-
mental Experimental Procedures and were the kind gifts of the following indi-
viduals: rabbit anti-VGlut (Aaron DiAntonio); guinea pig anti-Eve (Kosman et al.,
1998) (Dr. John Reinitz); mouse anti-Pburs (Aaron Hsueh). The rabbit anti-
Bursa and anti-CCAP antibodies were the same as in Luan et al. (2006), and
mouse anti-LacZ and mouse anti-EGFP were from Promega and Invitrogen,
respectively. Alexa 488 and Alexa Fluor 568 and 647 secondary antibodies
were from Invitrogen. Embryonic fluorescent in situ hybridization to confirm
the fidelity of expression in the ChaMI04508-Gal4 line used a riboprobell Reports 10, 1410–1421, March 3, 2015 ª2015 The Authors 1419
synthesized from the coding sequence of the VAChT gene, which is co-
expressed from the same genomic locus as Cha (Kitamoto et al., 1998). T7
RNA polymerase (New England Biolabs) was used to generate the riboprobe,
and VAChT mRNA was visualized using a sheep anti-DIG-POD antibody
(Roche). See the Supplemental Experimental Procedures for more details.
Fluorescent imaging of larval and adult CNS preparations was performed
with a Nikon C-1 confocal microscope using a 203 objective, and the
images shown are composites of separately acquired volume-rendered
images. A Leica TCS SP5 confocal microscope with a 633 oil-immersion
objective was used for imaging late embryonic and early larval ventral nerve
cords.
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